The Experts in Animal Health

printer friendly version

Brakke Consulting’s
Animal Health News & Notes for April 9, 2010

Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon, DVM, MBA
Brakke news
Pain Management Products report – now available
other news
Boehringer Ingelheim Vetmedica
Fujita Pharmaceuticals
Modern Veterinary Therapeutics

Pain management is one of the leading topics in veterinary medicine today.  The products represent a substantial market segment with potential still to be tapped. 
Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
  – overview of acute and chronic pain in small animals
  – review of current products
  – estimates of US sales and prices of leading products
  – pain management products in development
  – review of nutritional supplements used for chronic pain
  – review of therapeutic diets for joint care
  – 2010 survey of nearly 200 small animal veterinarians regarding use of pain management products
Pain Management Products for Dogs and Cats 2010 will be available for shipping on Monday, April 12, for a price of $5,500.  Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at 972-243-4033, or email
> Modern Veterinary Therapeutics, LLC announced that the FDA Center for Veterinary Medicine has approved its injectable analgesic Butorphine (butorphanol tartrate) for the relief of pain in cats caused by major or minor trauma, or pain associated with surgical procedures. (company press release)
> AgriLabs announced the launch of Colostrx Multi Species for use in foals, puppies, kittens, kids, lambs, fawns, alpacas, llamas and calves. Colostrx Multi Species has a guaranteed level of 20 grams of Globulin Protein per bag. (company press release) 
> IDEXX Laboratories, Inc. announced that it plans to develop a new corporate administrative facility, a projected investment of $50 million. The multi-story building, estimated at 200,000 sq. ft., will be designed to support 500 new jobs as well as provide an opportunity to consolidate 400 existing positions currently located at other locations in Westbrook, Maine. (company website)
> Farnam announced that Forshner’s Hoof Packing is returning to tack shop, feed store and farrier supply shelves with the same formula high performance horse owners and horseshoers have depended on for over 25 years. Forshner’s Hoof Packing packs into the hoof cavity to aid in preventing hardened frogs, contracted heels and hoof dryness. (company press release)
> JAPAN   Fujita Pharmaceuticals announced the Japanese launch of Fujita Milbemycin Tablets, a generic milbemycin oxime for the control of heartworm and gastrointestinal nematodes in dogs. (Animal Pharm)
> CHINA   Boehringer Ingelheim Vetmedica announced that it has obtained Chinese approval for its porcine circovirus type 2 (PCV2) vaccine, CircoFLEX. The company says the product is the first vaccine licensed for the prevention of the disease in China. (Animal Pharm)
> US – EQUINE HERPES   New Jersey animal health authorities are investigating a possible outbreak of a neurological type of equine herpes virus type 1. Horses at four farms in New Jersey have been quarantined to prevent the virus from spreading. The investigation of the outbreak started last week after it was reported that a couple of horses at a farm in County of Monmouth had to be euthanized after the results of a test revealed that they had a neurological form of EHV-1. (TopNews)
> SOUTH KOREA – FOOT AND MOUTH DISEASE   South Korea reported the discovery of a new outbreak of foot-and-mouth disease, less than a month after the nation declared itself free of the disease.  The disease was discovered in cattle at a farm in Ganghwa, 36 miles west of the capital Seoul. The government destroyed about 200 animals at the farm, limited traffic and carried out disinfection around the area. (Business Week)
> CANADA – GM PIGS   Environment Canada has given the go-ahead to Canadian researchers to raise the genetically modified “Enviropig” in a controlled research setting. The genetic modification enables the Enviropig to produce phytase, which breaks down phosphorous, in its salivary glands. As a result, the urine and feces excreted by the Enviropig have just 35% the phosphorous content of waste produced by traditionally bred pigs. (Pig e-news)
The newsletter is a short one this week.  Many of you must still be on Easter break!!  Hopefully you’ll be back to work next week creating interesting press releases that we can report. 
We continue to watch for additional product introductions that will drive new revenue in 2010.  Without new product introductions, we think it will be difficult for revenues in animal health to exceed 2009. 
We’ve recently been encouraged by the number of venture capital firms that are beginning to demonstrate interest in animal health. We need investment to stimulate and support innovation.  For those of you with new technology that needs funding, we want to encourage you to block the date of August 31, 2010 for the Second Animal Health Investment Forum that will be held in Kansas City.  Watch our newsletter and the KCAHC website for application information on this next meeting.
Have a great weekend!!
Ron Brakke
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
2735 Villa Creek, Suite 140
Dallas, TX  75234    USA

en_USEnglish (United States)